“…Among these, quinolin-2(1H)-one and its analogs are an important class of nitrogen-containing heterocycle scaffolds and are widely encountered in a myriad of pharmaceutical molecules and synthetic compounds ( Sliskovic et al, 1991 ; Suzuki et al, 2001 ; Bach et al, 2002 ; Kuethe et al, 2005 ) which display versatile biological and pharmacological activities ( McQuaid et al, 1992 ; Michael, 1995 ; Peifer et al, 2008 ), such as P2X7 receptor antagonist, rebamipide, and MAP kinase inhibitor ( Figure 1 ) ( Maignan et al, 2016 ; Tan et al, 2016 ; Miliutina et al, 2017 ; Wu et al, 2020 ). Various synthetic strategies have been achieved to construct the skeleton of such heterocycles, including Knorr synthesis ( Liu et al, 2012 ; Ma et al, 2023 ), Friedlander reactions ( Han et al, 2012 ), radical cyclization of acyclic precursors ( Kadnikov and Larock, 2004 ; Manley and Bilodeau, 2004 ), and other methods ( Fujita et al, 2004 ; Tsuritani et al, 2009 ; Berrino et al, 2012 ; Mai et al, 2014 ). The investigation of straightforward, atom-economic, environmentally acceptable, and green synthetic approaches to the construction of highly functionalized quinolin-2(1H)-ones remains a long-standing target and an active field of research in synthetic and medicinal chemistry.…”